search

All clinical trials

Results 465951-465960 of 470744

Balance Control and Maturation in Normal and Deaf Children Aged From 6 to 14 Years Old

Deaf Children

Balance disorders in children are poorly known, underestimated, and rarely assessed. Technologies to assess balance in children are almost non-existent, apart from a few exceptions. Such technologies are routinely used in adults for some decades, and are of considerable contribution in the diagnosis and treatment of adults balance disorders. The aim of this study is : to assess objectively children balance disorders. to provide technologies suitable for children balance assessement. to study children balance disorders suffering from sensorineural hearing loss.

Unknown status13 enrollment criteria

NT-proBNP for Evaluation of the Dyspneic Patient in the Emergency Room and the Medical Ward

Shortness of BreathAcute Exacerbation

The proposed study intends to evaluate the impact of the NT-proBNP assay on the diagnosis of heart failure in patients with dyspnea of unknown etiology presenting to the emergency room and admitted to the medical wards.

Unknown status3 enrollment criteria

Tongue Pressure Recording During Speech

Complete Toothless

This research is about tongue's pressure during speech, using a complete denture which allows respecting tongue and speech physiology at the best. A strain gauge transducer is placed inside this prosthodontics device. During speech, the pressure and the sounds are recording. The analysis of the twos signals should explain what pressure is needed for what sound. The comparison between old complete denture wearers and new one is realized to provide informations about tongue adaptation's phenomenon.

Unknown status2 enrollment criteria

Identifying Methylation Biomarkers for Monitoring Bladder Tumors

Bladder Cancer

To investigate the methylation status of 4-6 genes in Urine and matching bladder tissue biopsies, in order to find methylation markers for use in a noninvasive test in monitoring patients with bladder tumors.

Unknown status2 enrollment criteria

Serial Echocardiography After Subarachnoid Hemorrhage

Subarachnoid HemorrhageMyocardial Stunning1 more

There is increasing interest in myocardial abnormalities following central nervous system events, such as subarachnoid hemorrhage (SAH). These cardiac abnormalities include ECG changes, decreased cardiac output, decreased blood pressure, specific cardiac enzyme elevations, and segmental wall motion abnormalities (SWMA). Interestingly, wall motion abnormalities and ECG changes have shown to be reversible, and therefore the dysfunction has been described as neurogenic myocardial stunning. The pathophysiology of cardiac dysfunction following SAH has not yet been fully elucidated. Many reports (mainly case reports) have been published, but so far no study has investigated the frequency of these abnormalities in a prospective manner, have correlated the occurrence of the different cardiac abnormalities, and have assessed which clinical variables can predict cardiac dysfunction. And only a limited number of studies have related neurological outcome with cardiac dysfunction.

Unknown status4 enrollment criteria

Parkin Mutations and Their Functional Consequences

Parkinson's Disease

Parkinson's disease (PD) is the most frequent neurodegenerative disease with a prevalence of 2% over 65 years and because of this high prevalence as the population ages, it is a major problem of public health. An exhaustive repertory of not only parkin mutations in autosomal recessive forms of PD but also in other known genes such as DJ-1, PINK1 and LRRK2, is of major importance for both genetic counseling in families affected with PD and physiopathological approaches to this disease. Through a French network for the study of Parkinson's disease genetics and extended collaborations with European, Mediterranean and other various countries, a total of 2934 subjects including 1683 patients and 1251 unaffected individuals has been collected since 2002. These samples consisted of 122 families with autosomal recessive PD, 285 cases of isolated early onset PD, 110 autosomal recessive and 129 autosomal dominant families with late onset PD, 201 isolated late onset PD cases and 250 matched controls. DNAs from all subjects are now available, lymphocytes and lymphoblastoid cell lines have been stored for most patients from France and recently, fresh fibroblasts have been obtained for some individuals. The genetic approach to autosomal recessive PD is focused on the identification of mutations in the parkin gene but also on the screening of DJ-1, PINK1 and LRRK2 genes.

Unknown status5 enrollment criteria

Study of Genetic Risk Factors for Spina Bifida and Anencephaly

Spina BifidaAnencephaly

The purpose of this study is to describe the genetic contribution to the neural tube defects spina bifida (SB) and anencephaly (A), which includes identifying patients, defining the roles of certain genes, and studying gene-environment interactions.

Unknown status3 enrollment criteria

Study of the Approximate Entropy of Adrenocorticotropic Hormone and Cortisol Secretion in Patients...

Brain InjuryCraniocerebral Trauma

OBJECTIVES: I. Determine the randomness of adrenocorticotropic hormone (ACTH) and cortisol secretion using approximate entropy in patients who have sustained a head injury. II. Determine the correlation between randomness of ACTH and cortisol secretion and stages of sleep in these patients.

Unknown status17 enrollment criteria

Study of Energy Expenditure in Infants With Ventricular Septal Defects

Heart Septal DefectsVentricular

OBJECTIVES: I. Compare the total daily energy expenditure in infants with ventricular septal defects vs healthy control infants.

Unknown status8 enrollment criteria

Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic...

I Cell DiseaseFucosidosis10 more

OBJECTIVES: I. Evaluate bronchoalveolar lavage fluid and serum obtained from pediatric patients with storage disorders prior to allogeneic hematopoietic stem cell transplantation (HSCT) for the presence of proinflammatory cytokines and for the production of nitric oxide by alveolar macrophages to identify possible risk factors for pulmonary complications. II. Investigate the underlying mechanism for the development of significant pulmonary complications in these patients during HSCT. III. Evaluate bronchoalveolar lavage fluid and serum obtained from these same patients at the time a pulmonary complication develops post-HSCT, or at 60 days post-HSCT if there has been no pulmonary complications.

Unknown status1 enrollment criteria
1...465954659646597...47075